Framlington offers discount on biotech and health Isas

Framlington is offering a 1% discount on its initial charge for investments of £7000 before the end of this year's Isa season, into its new fund the Framlington Biotech Isa and the Framlington Health Isa.. The Biotech Fund was launched in November 2001, which takes a minimum investment of £1000 and regular premium payments of £50, has raised £18m so far. Its portfolio comprises of around 70 global stocks, with 80% of investment in the US. Annual management charge of the Biotech Fund is 1.75% with a standard initial charge of 5.5%. The Health ISA has minimum investment of £...